| Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues H Kosanam, I Prassas, CC Chrystoja, I Soleas, A Chan, ... Molecular & Cellular Proteomics 12 (10), 2820-2832, 2013 | 110 | 2013 |
| Whole genome sequencing as a diagnostic test: challenges and opportunities CC Chrystoja, EP Diamandis Clinical chemistry 60 (5), 724-733, 2014 | 95 | 2014 |
| Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery I Prassas, CC Chrystoja, S Makawita, EP Diamandis BMC medicine 10, 1-13, 2012 | 67 | 2012 |
| Achalasia-specific quality of life after pneumatic dilation or laparoscopic Heller myotomy with partial fundoplication: a multicenter, randomized clinical trial CC Chrystoja, GE Darling, NE Diamant, PP Kortan, GA Tomlinson, ... Official journal of the American College of Gastroenterology| ACG 111 (11 …, 2016 | 55 | 2016 |
| False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125 I Prassas, D Brinc, S Farkona, F Leung, A Dimitromanolakis, CC Chrystoja, ... Clinical Chemistry 60 (2), 381-388, 2014 | 52 | 2014 |
| Pancreatic cancer CC Chrystoja, EP Diamandis, R Brand, F Rückert, R Haun, R Molina Clinical chemistry 59 (1), 41-46, 2013 | 30 | 2013 |
| LAMC2: a promising new pancreatic cancer biomarker identified by proteomic analysis of pancreaticadenocarcinoma tissues H Kosanam, I Prassas, CC Chrystoja, I Soleas, A Chan, ... Mol Cell Proteomics 12 (10), 2820-2832, 2013 | 9 | 2013 |
| Transition to independent surgical practice and burnout among early career general Surgeons M Firdouse, C Chrystoja, S de Montbrun, J Escallon, T Cil Surgical Innovation 29 (2), 249-257, 2022 | 5 | 2022 |
| Bias estimation in study design: a meta-epidemiological analysis of transcatheter versus surgical aortic valve replacement S Youn, SA Wong, C Chrystoja, G Tomlinson, HC Wijeysundera, CM Bell, ... BMC surgery 21 (1), 285, 2021 | 5 | 2021 |
| Cancer Biomarkers and Methods of Use EP Diamandis, I Prassas, S Makawita, C Chrystoja, HM Kosanam US Patent App. 14/385,449, 2015 | 2 | 2015 |
| Canadian Surgery Forum 201801. Laparoscopic splenectomy with management of intraoperative hemorrhage02. Incisional hernia after midline versus transverse specimen extraction … S Jayaraman, L Lee, M Schellenberg, J Jung, J Taylor, P Serrano, ... Canadian Journal of Surgery 61 (4 Suppl 1), S94-S174, 2018 | | 2018 |
| Variation with Structures of Care among Hospitals Performing Colorectal Cancer Surgery in Ontario CC Chrystoja, JK Ramjist, NN Baxter, M Simunovic, R Sutradhar, L Lix, ... Journal of the American College of Surgeons 223 (4), S122, 2016 | | 2016 |
| 2016 Canadian Surgery Forum01 Intragastric balloon for management of severe obesity: a systematic review. 02 Treating type 2 diabetes with bariatric surgery—a predictive tool … E Yorke, JT Dang, WYL Sun, S Rieder, NJ Switzer, A Chow, SE Stogryn, ... Canadian Journal of Surgery 59 (4 Suppl 1), S77-S147, 2016 | | 2016 |
| Cancer biomarkers and methods of use EP Diamandis, I PRASSAS, S MAKAWITA, C CHRYSTOJA, ... | | 2013 |
| Abstract A3: Validation of candidate serum biomarkers demonstrates the potential of CUZD1 and LAMC2 to complement CA19. 9 for pancreatic cancer diagnosis. C Chrystoja, H Kosanam, I Prassas, A Chan, A Dimitromanolakis, ... Cancer Research 72 (14_Supplement), A3-A3, 2012 | | 2012 |
